InVitro International, Inc. IVRO
OTC PK
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Net Income | 33.90K | ||||
| Total Depreciation and Amortization | 900.00 | ||||
| Total Amortization of Deferred Charges | 200.00 | ||||
| Total Other Non-Cash Items | 1.10K | ||||
| Change in Net Operating Assets | -41.90K | ||||
| Cash from Operations | -5.70K | ||||
| Capital Expenditure | -- | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -9.90K | ||||
| Cash from Investing | -9.90K | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | -- | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -15.70K | ||||